IDIBAPS participates in a 5.7M European project to improve knowledge on liver cancer
The Translational Reserarch in Hepatic Oncology IDIBAPS group, led by Dr. Josep M. Llovet, in collaboration with Dr. Roser Pinyol and 8 more researc1
The Translational Reserarch in Hepatic Oncology IDIBAPS group, led by Dr. Josep M. Llovet, in collaboration with Dr. Roser Pinyol and 8 more researc1
Researchers from the August Pi i Sunyer Biomedical Research Institute (IDIBAPS) and the Hospital Clínic of Barcelona, in collaboration with qGenomics1
A study published in the New England Journal of Medicine (NEJM) shows that the combination of two drugs (ambrisentan and tadalafil) is more effective1
A study led by researchers at the Biomedical Research Institute of Barcelona CSIC (IIBB-CSIC) and the August Pi i Sunyer Biomedical Research Institu1
The prestigious journal The Lancet publishes a seminar on community-acquired pneumonia written by IDIBAPS researchers. The article reviews the epidem1
Dr. Marc Claret, head of the IDIBAPS group Neural Control of Metabolism, has received one of 63 BBVA Foundation Grants to Researchers and Culture Cr1
Dr. Eduard Vieta, head of the Psychiatry and Psychology department at Hospital Clínic and head of the IDIBAPS research group Biological bases of psyc1
Doctors and researchers from Hospital Clínic and IDIBAPS were awarded in the second Vall d’Hebron Research Institute (VHIR) Health Innovation Contes1
The Spanish Agency for Medicines and Health Products (AEMPS) has approved a clinical trial in humans with an Antigen-Specific therapy with dendritic1
A study, published today in the journal Nature, marks a milestone in the understanding of chronic lymphocytic leukemia, the most common leukemia in1